Health Risk Analysis:

Technical Adequacy in Three Selected Cases

PEMD-87-14: Published: Sep 30, 1987. Publicly Released: Sep 30, 1987.

Additional Materials:


Office of Public Affairs
(202) 512-4800

GAO evaluated the risk analysis processes used by the Food and Drug Administration (FDA), the Occupational Safety and Health Administration (OSHA), and the Environmental Protection Agency (EPA) to identify possible weaknesses and strengths in the processes.

GAO found that: (1) risk assessment work generally met acceptable technical and scientific criteria; (2) FDA and OSHA did a credible job of reviewing and evaluating available evidence on a hazard; and (3) problems in risk assessment were primarily related to data availability. GAO also found that: (1) there were significant problems in risk management work; (2) FDA and EPA poorly documented the development and evaluation of risk management options and decisionmaking processes; (3) the extent and quality of risk management guidelines varied greatly between and within the agencies; and (4) none of the agencies conducted follow-up evaluations of the regulations to determine if they were achieving the intended risk reduction effects.

Mar 19, 2018

Mar 8, 2018

Feb 20, 2018

Feb 8, 2018

Feb 5, 2018

Jan 30, 2018

Jan 23, 2018

Jan 17, 2018

Jan 16, 2018

Looking for more? Browse all our products here